Treatment of mild to moderate stress urinary incontinence with a novel polycaprolactonebased bioresorbable urethral bulking agent. Urogynaecologia, [S. l.], v. 34, n. 1, 2022. DOI: 10.4081/uij.2022.287. Disponível em: https://www.urogynaecologia.org/uij/article/view/287. Acesso em: 13 mar. 2025.